ELVN Enliven Therapeutics, Inc.
Nasdaq · SEC CIK 1672619 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $76.73M 38 sales by 9 insiders
- Filings on record
- 300 since 2021-07-01, latest 2026-09-21 17:23
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% | — | $51.68M |
| Derynck Mika K | Dir | — | $9.56M |
| Collins Helen Louise | Chief MEDICAL Off | — | $5.39M |
| Lyssikatos Joseph P | CSO | — | $4.88M |
| Patel Anish | COO | — | $1.74M |
| Hohl Benjamin | CFO | — | $1.60M |
| Kunkel Lori Anne | Dir | — | $850.3K |
| Kintz Samuel | Pres AND CEO, Dir | — | $613.6K |
| Heyman Richard A. | Dir | — | $413.4K |
Transactions 332
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-26 | 2025-03-24 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,000 | 24.0K | +4% | +$2,480 |
| D | 2025-03-26 | 2025-03-24 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.50 | -1,000 | 23.0K | -4% | -$22.5K |
| I | 2025-03-21 | 2025-03-19 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $20.61 | -12.5K | 1.00M | -1% | -$257.6K |
| I | 2025-03-19 | 2025-03-17 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $20.83 | -12.5K | 990.4K | -1% | -$260.4K |
| I | 2025-03-11 | 2025-03-07 | ELVN | Patel Anish | COO | S - Sale | $21.44 | -6,667 | 323.3K | -2% | -$142.9K |
| D | 2025-03-06 | 2025-03-04 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +10.0K | 23.0K | +77% | +$24.8K |
| D | 2025-03-03 | 2025-02-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $20.41 | -3,250 | 13.0K | -20% | -$66.3K |
| D | 2025-03-03 | 2025-02-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 16.2K | +25% | +$8,060 |
| DI | 2025-02-10 | 2025-02-07 | ELVN | Patel Anish | COO | S - Sale | $21.93 | -6,667 | 330.0K | -2% | -$146.2K |
| D | 2025-02-07 | 2025-02-05 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,000 | 14.0K | +8% | +$2,480 |
| D | 2025-02-07 | 2025-02-05 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.52 | -1,000 | 13.0K | -7% | -$22.5K |
| D | 2025-01-29 | 2025-01-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $21.59 | -3,250 | 13.0K | -20% | -$70.2K |
| D | 2025-01-29 | 2025-01-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 16.2K | +25% | +$8,060 |
| DM | 2025-01-10 | 2025-01-07 | ELVN | Patel Anish | COO | M - OptEx | $1.81 | +21.7K | 21.7K | New | +$39.3K |
| DM | 2025-01-10 | 2025-01-07 | ELVN | Patel Anish | COO | S - Sale+OE | $24.18 | -21.7K | 0 | -100% | -$524.6K |
| DMI | 2025-01-10 | 2025-01-07 | ELVN | Patel Anish | COO | S - Sale+OE | $24.18 | -6,667 | 336.6K | -2% | -$161.2K |
| DM | 2025-01-07 | 2024-12-13+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +14.0K | 14.0K | New | +$34.7K |
| D | 2025-01-07 | 2025-01-03 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $25.04 | -1,000 | 13.0K | -7% | -$25.0K |
| DM | 2024-12-31 | 2024-12-27+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +4,250 | 900 | New | +$10.5K |
| DM | 2024-12-31 | 2024-12-27+ | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.23 | -4,250 | 0 | -100% | -$94.5K |
| D | 2024-12-02 | 2024-11-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +5,250 | 5,250 | New | +$13.0K |
| DM | 2024-12-02 | 2024-11-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $24.89 | -5,250 | 0 | -100% | -$130.7K |
| D | 2024-10-30 | 2024-10-28 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +6,250 | 6,250 | New | +$15.5K |
| DM | 2024-10-30 | 2024-10-28 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $28.55 | -6,250 | 650 | -91% | -$178.5K |
| I | 2024-10-22 | 2024-10-18 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $30.00 | -847 | 1.02M | -0.1% | -$25.4K |
| I | 2024-10-22 | 2024-10-18 | ELVN | Patel Anish | COO | S - Sale | $30.00 | -716 | 343.3K | -0.2% | -$21.5K |
| I | 2024-10-22 | 2024-10-18 | ELVN | Heyman Richard A. | Dir | S - Sale | $30.00 | -753 | 27.2K | -3% | -$22.6K |
| 2024-10-22 | 2024-10-18 | ELVN | Heyman Richard A. | Dir | S - Sale | $30.00 | -817 | 123.7K | -0.7% | -$24.5K | |
| D | 2024-10-22 | 2024-10-18 | ELVN | Collins Helen Louise | Chief MEDICAL Off | S - Sale+OE | $30.00 | -816 | 0 | -100% | -$24.5K |
| D | 2024-10-22 | 2024-10-18 | ELVN | Collins Helen Louise | Chief MEDICAL Off | M - OptEx | $2.48 | +816 | 816 | New | +$2,024 |
| D | 2024-10-22 | 2024-10-18 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +814 | 814 | New | +$2,019 |
| D | 2024-10-22 | 2024-10-18 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $30.00 | -814 | 0 | -100% | -$24.4K |
| I | 2024-10-22 | 2024-10-18 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $30.00 | -924 | 1.00M | -0.1% | -$27.7K |
| 2024-10-17 | 2024-10-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.67 | -1,270 | 124.5K | -1% | -$35.1K | |
| MI | 2024-10-10 | 2024-10-08+ | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $28.11 | -51.1K | 1.05M | -5% | -$1.44M |
| MI | 2024-10-10 | 2024-10-08+ | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $28.06 | -30.0K | 1.01M | -3% | -$841.2K |
| DM | 2024-10-10 | 2024-10-08 | ELVN | Ballal Rahul D. | Dir | M - OptEx | $14.10 | +10.4K | 32.8K | +47% | +$146.9K |
| D | 2024-10-10 | 2024-10-08 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $28.17 | -10.4K | 22.3K | -32% | -$293.5K |
| 2024-10-08 | 2024-10-04 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.51 | -2,825 | 125.8K | -2% | -$77.7K | |
| MI | 2024-10-08 | 2024-10-04+ | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $27.51 | -14.9K | 1.03M | -1% | -$410.9K |
| DM | 2024-10-08 | 2024-10-04+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +11.5K | 10.2K | New | +$28.5K |
| DM | 2024-10-08 | 2024-10-04+ | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $27.51 | -11.5K | 0 | -100% | -$316.0K |
| MI | 2024-10-08 | 2024-10-04+ | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $27.54 | -10.2K | 1.07M | -0.9% | -$281.7K |
| 2024-10-03 | 2024-10-01 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.54 | -518 | 128.6K | -0.4% | -$14.3K | |
| I | 2024-10-03 | 2024-10-01 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $27.54 | -527 | 1.08M | -0.0% | -$14.5K |
| I | 2024-10-03 | 2024-10-01 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $27.54 | -526 | 1.05M | -0.1% | -$14.5K |
| D | 2024-10-03 | 2024-10-01 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +521 | 521 | New | +$1,292 |
| D | 2024-10-03 | 2024-10-01 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $27.54 | -521 | 0 | -100% | -$14.3K |
| DM | 2024-10-01 | 2024-09-27+ | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +6,250 | 4,250 | New | +$15.5K |
| DM | 2024-10-01 | 2024-09-27+ | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $24.61 | -6,250 | 0 | -100% | -$153.8K |
| 2024-09-18 | 2024-09-16 | ELVN | Heyman Richard A. | Dir | S - Sale | $22.41 | -1,270 | 129.1K | -1.0% | -$28.5K | |
| MI | 2024-09-03 | 2024-08-29 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $22.48 | -12.0K | 1.08M | -1% | -$269.8K |
| D | 2024-08-29 | 2024-08-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.54 | -4,250 | 0 | -100% | -$95.8K |
| D | 2024-08-29 | 2024-08-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +4,250 | 4,250 | New | +$10.5K |
| I | 2024-08-28 | 2024-08-26 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $22.89 | -12.0K | 1.05M | -1% | -$274.7K |
| M | 2024-08-19 | 2024-08-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $23.25 | -1,270 | 130.4K | -1.0% | -$29.5K |
| I | 2024-08-02 | 2024-07-31 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $27.56 | -3,099 | 1.09M | -0.3% | -$85.4K |
| D | 2024-08-02 | 2024-07-31 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +991 | 991 | New | +$2,458 |
| D | 2024-08-02 | 2024-07-31 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $27.53 | -991 | 0 | -100% | -$27.3K |
| I | 2024-08-02 | 2024-07-31 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $27.56 | -2,270 | 1.06M | -0.2% | -$62.6K |
| I | 2024-08-02 | 2024-07-31 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.50 | -649 | 27.9K | -2% | -$17.8K |
| 2024-08-02 | 2024-07-31 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.51 | -1,702 | 131.6K | -1% | -$46.8K | |
| DM | 2024-07-31 | 2024-07-29 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $26.68 | -5,250 | 0 | -100% | -$140.1K |
| D | 2024-07-31 | 2024-07-29 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +5,250 | 5,250 | New | +$13.0K |
| MI | 2024-07-31 | 2024-07-29 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $26.70 | -12.0K | 1.09M | -1% | -$320.4K |
| MI | 2024-07-29 | 2024-07-25 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $24.92 | -12.0K | 1.06M | -1% | -$299.1K |
| 2024-07-17 | 2024-07-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $24.80 | -1,270 | 133.3K | -0.9% | -$31.5K | |
| MI | 2024-07-16 | 2024-07-12+ | ELVN | Patel Anish | COO | S - Sale | $25.06 | -50.0K | 345.6K | -13% | -$1.25M |
| D | 2024-07-16 | 2024-07-12 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,000 | 3,000 | New | +$7,440 |
| D | 2024-07-16 | 2024-07-12 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $25.07 | -3,000 | 0 | -100% | -$75.2K |
| I | 2024-07-03 | 2024-07-01 | ELVN | Lyssikatos Joseph P | CSO | S - Sale | $22.89 | -12.0K | 1.11M | -1% | -$274.7K |
| DM | 2024-07-01 | 2024-06-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.57 | -4,250 | 0 | -100% | -$95.9K |
| D | 2024-07-01 | 2024-06-27 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +4,250 | 4,250 | New | +$10.5K |
| MI | 2024-06-27 | 2024-06-25 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale | $21.66 | -12.0K | 1.08M | -1% | -$259.9K |
| 2024-06-20 | 2024-06-17 | ELVN | Heyman Richard A. | Dir | S - Sale | $21.48 | -1,270 | 134.6K | -0.9% | -$27.3K | |
| D | 2024-06-10 | 2024-06-06 | ELVN | Patel Anish | COO | M - OptEx | $2.48 | +1,133 | 1,133 | New | +$2,810 |
| D | 2024-06-10 | 2024-06-06 | ELVN | Patel Anish | COO | S - Sale+OE | $20.06 | -1,133 | 0 | -100% | -$22.7K |
| DM | 2024-05-31 | 2024-05-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $21.73 | -12.0K | 0 | -100% | -$260.8K |
| D | 2024-05-31 | 2024-05-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| D | 2024-05-30 | 2024-05-28 | ELVN | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2024-05-30 | 2024-05-28 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $23.18 | -12.0K | 0 | -100% | -$278.2K |
| DM | 2024-05-30 | 2024-05-28 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $23.18 | -4,250 | 10 | -100% | -$98.5K |
| D | 2024-05-30 | 2024-05-28 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +4,250 | 4,250 | New | +$10.5K |
| MI | 2024-05-20 | 2024-05-16 | ELVN | Gupta Rishi | Dir, 10% | S - Sale | $22.14 | -1.03M | 7.66M | -12% | -$22.88M |
| MI | 2024-05-20 | 2024-05-16 | ELVN | OrbiMed Capital GP VII LLC | Dir, 10% | S - Sale | $22.14 | -1.03M | 7.66M | -12% | -$22.88M |
| 2024-05-20 | 2024-05-16 | ELVN | Heyman Richard A. | Dir | S - Sale | $23.74 | -1,270 | 135.9K | -0.9% | -$30.1K | |
| D | 2024-05-16 | 2024-05-14 | ELVN | Patel Anish | COO | S - Sale+OE | $25.00 | -1,107 | 0 | -100% | -$27.7K |
| D | 2024-05-16 | 2024-05-14 | ELVN | Patel Anish | COO | M - OptEx | $2.48 | +1,107 | 1,107 | New | +$2,745 |
| D | 2024-05-13 | 2024-05-09 | ELVN | Patel Anish | COO | S - Sale+OE | $25.06 | -260 | 0 | -100% | -$6,516 |
| D | 2024-05-13 | 2024-05-09 | ELVN | Patel Anish | COO | M - OptEx | $2.48 | +260 | 260 | New | +$644.80 |
| D | 2024-05-08 | 2024-05-06 | ELVN | Patel Anish | COO | M - OptEx | $2.48 | +4,875 | 4,875 | New | +$12.1K |
| D | 2024-05-08 | 2024-05-06 | ELVN | Patel Anish | COO | S - Sale+OE | $22.72 | -4,875 | 0 | -100% | -$110.8K |
| D | 2024-05-07 | 2024-05-03 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.50 | -1,000 | 0 | -100% | -$22.5K |
| D | 2024-05-07 | 2024-05-03 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,000 | 1,000 | New | +$2,480 |
| D | 2024-05-01 | 2024-04-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
| DM | 2024-05-01 | 2024-04-29 | ELVN | Lyssikatos Joseph P | CSO, Dir | S - Sale+OE | $17.91 | -12.0K | 1,013 | -92% | -$214.9K |
| D | 2024-05-01 | 2024-04-29 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $16.97 | -3,250 | 0 | -100% | -$55.2K |
| D | 2024-05-01 | 2024-04-29 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +3,250 | 3,250 | New | +$8,060 |
| D | 2024-04-29 | 2024-04-25 | ELVN | Kintz Samuel | Pres AND CEO, Dir | S - Sale+OE | $16.89 | -12.0K | 0 | -100% | -$202.7K |
| D | 2024-04-29 | 2024-04-25 | ELVN | Kintz Samuel | Pres AND CEO, Dir | M - OptEx | $1.12 | +12.0K | 12.0K | New | +$13.4K |
Purchase Sale Sale after option exercise All abbreviations